VRBPAC: Pfizer 5-11 COVID Vaccine – October 26, 2021

AIM Members - Today, The FDA VRBPAC committee voted 17 YES - 1 ABSTAIN to recommend authorization of the Pfizer BioNTech 10ug COVID-19 for children 5-11 years under Emergency Use Authorization: “Based on the…

ASTHO Congressional Briefing Remarks

Consistent and accurate vaccine allocations and projections are needed for planning, and strong communication with the public about what is happening and what they can expect.

Legacy Council

AIM launched an advisory group called the Legacy Council in April 2023. The Legacy Council is comprised of former and retired immunization program managers who provide high-level guidance to AIM…

AIM Policy Summary: May 20, 2022

Legislation on authority to administer COVID-19 vaccines was enacted in two states. Read up on the latest legislation in jurisdictions compiled by AIM staff.

Corporate Alliance

The Corporate Alliance Program provides critical support to AIM to achieve our mission.
Back To Top
Search